The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

CORONARY INTERVENTIONS

Polymer-free drug-coated coronary stents are cost-effective in patients at high bleeding risk: economic evaluation of the LEADERS FREE trial

EuroIntervention 2018;13:1688-1695 published online September 2017. DOI: 10.4244/EIJ-D-17-00286

1. Assistance Publique Hopitaux de Paris, URC Eco & Santé Publique, Hôpital Henri Mondor, Créteil, France; 2. Université Paris Est Créteil, Créteil, France; 3. INSERM ECEVE UMR 1123, Paris, France; 4. Biosensors, Morges, Switzerland; 5. Hôpital Privé

Aims: In patients at high risk of bleeding who undergo PCI, the Biolimus A9 polymer-free drug-coated stent (DCS) has superior efficacy and safety compared to a bare metal stent (BMS). We

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article

Diagnostic performance of a Lattice Boltzmann-based method for CT-based fractional flow reserve